Home / Science / Dog's Dementia Offers Hope for Alzheimer's Research
Dog's Dementia Offers Hope for Alzheimer's Research
23 Mar
Summary
- Ralph, a dog with dementia, participated in the Dog Aging Project.
- Canine and human brains show similar dementia-related changes.
- Drug rapamycin showed potential in reducing brain inflammation.
Ralph, a cherished family dog, was diagnosed with dementia in February 2025 after exhibiting unusual behavior. His family enrolled him in the Dog Aging Project, a major initiative studying canine aging. This project involves over 50,000 dogs and aims to improve both canine and human health.
Neuropathologist Dr. Dirk Keene highlighted the significant structural similarities between dog and human brains, particularly in how dementia causes shrinkage and enlarged cavities. This makes canine dementia a valuable model for understanding human neurodegenerative diseases.
Comparative psychologist Evan MacLean observed Ralph's cognitive impairment through memory tests, where Ralph struggled to recall the location of a hidden treat. An MRI scan later revealed fluid-filled pockets in Ralph's brain, indicative of shrinkage.
Following Ralph's passing in December 2025, his brain was examined as part of a pilot study on the drug rapamycin. Preliminary findings suggest rapamycin may reduce inflammation in the brain, a common factor in dementia. The Rowe family expressed pride in Ralph's contribution to science, finding comfort in his potential to help future research.
